Compagno, S.; Casadio, C.; Galvani, L.; Rosellini, M.; Marchetti, A.; Tassinari, E.; Piazza, P.; Mottaran, A.; Santoni, M.; Schiavina, R.;
et al. Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives. J. Clin. Med. 2024, 13, 5738.
https://doi.org/10.3390/jcm13195738
AMA Style
Compagno S, Casadio C, Galvani L, Rosellini M, Marchetti A, Tassinari E, Piazza P, Mottaran A, Santoni M, Schiavina R,
et al. Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives. Journal of Clinical Medicine. 2024; 13(19):5738.
https://doi.org/10.3390/jcm13195738
Chicago/Turabian Style
Compagno, Samuele, Chiara Casadio, Linda Galvani, Matteo Rosellini, Andrea Marchetti, Elisa Tassinari, Pietro Piazza, Angelo Mottaran, Matteo Santoni, Riccardo Schiavina,
and et al. 2024. "Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives" Journal of Clinical Medicine 13, no. 19: 5738.
https://doi.org/10.3390/jcm13195738
APA Style
Compagno, S., Casadio, C., Galvani, L., Rosellini, M., Marchetti, A., Tassinari, E., Piazza, P., Mottaran, A., Santoni, M., Schiavina, R., Massari, F., & Mollica, V.
(2024). Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives. Journal of Clinical Medicine, 13(19), 5738.
https://doi.org/10.3390/jcm13195738
